AstraZeneca PLC (AZN)

194.91 +0.69 (+0.36%) USD  |  NYSE  |  Mar 09, 16:00
195.76 +0.85 (+0.44%) After-Hours: 19:41
More

AstraZeneca CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for AZN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
GSK Plc Upgrade
Mereo BioPharma Group Plc Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Biodexa Pharmaceuticals Plc --
Moderna, Inc. Upgrade